Avinger Inc.

0.47
-0.13 (-21.40%)
At close: Feb 14, 2025, 3:59 PM
-21.40%
Bid n/a
Market Cap 1.52M
Revenue (ttm) 7.26M
Net Income (ttm) -18.61M
EPS (ttm) -8.76
PE Ratio (ttm) -0.05410958904109589
Forward PE -0.64
Analyst Buy
Ask n/a
Volume 2,592,021
Avg. Volume (20D) 3,195,863
Open 0.56
Previous Close 0.60
Day's Range 0.46 - 0.61
52-Week Range 0.36 - 4.37
Beta 1.09

About AVGR

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment por...

Sector Healthcare
IPO Date Jan 30, 2015
Employees 68
Stock Exchange NASDAQ
Ticker Symbol AVGR
Full Company Profile

Advertisement

Analyst Forecast

According to 1 analyst ratings, the average rating for AVGR stock is "Buy." The 12-month stock price forecast is $5, which is an increase of 954.85% from the latest price.

Stock Forecasts

Next Earnings Release

Avinger Inc. is scheduled to release its earnings on May 2, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+42.62%
Avinger shares are trading higher after the compan... Unlock content with Pro Subscription
4 months ago
+46.05%
Avinger shares are trading higher after the company announced it has received a Notice of Allowance for a U.S. patent titled "Catheter Device With Detachable Distal End (For The Treatment Of Peripheral Artery Disease)."